BN-82451

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBN-82451
Drug Alias NameBN-82451BN-82451B
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitorsSodium channel alpha subunit blockersMonoamine oxidase B inhibitors
TargetsSodium channel alpha subunitMonoamine oxidase BCyclooxygenases
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsen
Active IndicationsN/A
Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A